Skip to main content
Equibles
APTOF logo

APTOF · Aptose Biosciences Inc.

Track APTOF — free

Use APTOF with AI

Ask our own analyst here, or connect this data to the AI you already use.

Ask ALVIS about APTOF

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$1.69 +0.00 (+0.00%) At close · Jul 3
Going-concern doubt — flagged May 13, 2026

Substantial doubt about the company's ability to continue as a going concern.

“our ability to continue as a going concern; - our need to raise substantial additional capital in the near future and our ability to raise such funds when needed and on acceptable terms; - if a financing is completed, it may not be a large enough financing to fully fund the company's operations”
View the 10-Q filed May 13, 2026
Market Cap
$4.31M
Shares
2.55M

Aptose Biosciences Inc. Earnings Call Transcripts

Every quarterly earnings call for Aptose Biosciences Inc. (APTOF) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.

Revenue & result across quarters

Revenue Net income YoY up YoY down artefacts
· $ −$13.25M '20 Q3 20-11-10 · $ −$14.71M '20 Q4 21-03-23 · $ −$16.23M '21 Q1 21-05-04 · $ −$13.47M '21 Q2 21-08-03 · $ −$11.33M '21 Q3 21-11-12 · $ −$24.32M '21 Q4 22-03-22 · $ −$11.48M '22 Q1 22-05-09 · $ −$10.56M '22 Q2 22-08-02 · $ −$9.78M '22 Q3 22-11-01 · $ −$10.00M '22 Q4 23-03-23 · $ −$13.68M '23 Q1 23-05-08 · $ −$14.13M '23 Q2 23-08-10 · $ −$11.45M '23 Q3 23-11-09 · $ −$11.96M '23 Q4 24-03-26 · $ −$9.64M '24 Q1 24-05-14 LATEST · $ −$7.04M '25 Q2 25-08-13
Earnings call
FY25 · Q2
2025-08-13
Aptose Biosciences Inc. Q2 FY2025 Earnings Call
Revenue
$
Diluted EPS
$-2.76
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2024-05-14
Aptose Biosciences Inc. Q1 FY2024 Earnings Call
Revenue
$
Diluted EPS
$-22.02
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2024-03-26
Aptose Biosciences Inc. Q4 FY2023 Earnings Call
Revenue
$
Diluted EPS
$-47.10
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q3
2023-11-09
Aptose Biosciences Inc. Q3 FY2023 Earnings Call
Revenue
$
Diluted EPS
$-52.80
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2023-08-10
Aptose Biosciences Inc. Q2 FY2023 Earnings Call
Revenue
$
Diluted EPS
$-68.10
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2023-05-08
Aptose Biosciences Inc. Q1 FY2023 Earnings Call
Revenue
$
Diluted EPS
$-66.60
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2023-03-23
Aptose Biosciences Inc. Q4 FY2022 Earnings Call
Revenue
$
Diluted EPS
$-50.10
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q3
2022-11-01
Aptose Biosciences Inc. Q3 FY2022 Earnings Call
Revenue
$
Diluted EPS
$-49.80
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q2
2022-08-02
Aptose Biosciences Inc. Q2 FY2022 Earnings Call
Revenue
$
Diluted EPS
$-49.80
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q1
2022-05-09
Aptose Biosciences Inc. Q1 FY2022 Earnings Call
Revenue
$
Diluted EPS
$-54.30
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2022-03-22
Aptose Biosciences Inc. Q4 FY2021 Earnings Call
Revenue
$
Diluted EPS
$-121.50
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY21 · Q3
2021-11-12
Aptose Biosciences Inc. Q3 FY2021 Earnings Call
Revenue
$
Diluted EPS
$-58.50
Rev · 7q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q2
2021-08-03
Aptose Biosciences Inc. Q2 FY2021 Earnings Call
Revenue
$
Diluted EPS
$-67.50
Rev · 6q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q1
2021-05-04
Aptose Biosciences Inc. Q1 FY2021 Earnings Call
Revenue
$
Diluted EPS
$-81.00
Rev · 5q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q4
2021-03-23
Aptose Biosciences Inc. Q4 FY2020 Earnings Call
Revenue
$
Rev · 4q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY20 · Q3
2020-11-10
Aptose Biosciences Inc. Q3 FY2020 Earnings Call
Revenue
$
Rev · 3q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q2
2020-08-05
Aptose Biosciences Inc. Q2 FY2020 Earnings Call
Revenue
$
Rev · 2q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q1
2020-05-05
Aptose Biosciences Inc. Q1 FY2020 Earnings Call
Revenue
$
Audio Transcript Slides 8-K10-Q
Earnings call
FY19 · Q4
2020-03-10
Aptose Biosciences Inc. Q4 FY2019 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-K
Showing 1–19 of 19 earnings calls
Key facts CIK 882361 CUSIP 03835T408 13F (30d) 2 filings 2 filers Visit website Investor relations

Report a Problem

Category
Description
Email (optional, for follow-up)